KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Non Operating Investment Income (2020 - 2024)

Historic Non Operating Investment Income for Biolife Solutions (BLFS) over the last 4 years, with Q2 2024 value amounting to -$4.1 million.

  • Biolife Solutions' Non Operating Investment Income changed N/A to -$4.1 million in Q2 2024 from the same period last year, while for Jun 2025 it was -$4.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of -$4.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Biolife Solutions reported Non Operating Investment Income of -$4.1 million as of Q2 2024.
  • Biolife Solutions' Non Operating Investment Income's 5-year high stood at $1.1 million during Q3 2020, with a 5-year trough of -$4.1 million in Q2 2024.
  • Over the past 4 years, Biolife Solutions' median Non Operating Investment Income value was $12500.0 (recorded in 2020), while the average stood at -$442166.7.
  • Within the past 5 years, the most significant YoY rise in Biolife Solutions' Non Operating Investment Income was 12336.96% (2023), while the steepest drop was 12336.96% (2023).
  • Over the past 4 years, Biolife Solutions' Non Operating Investment Income (Quarter) stood at $209000.0 in 2020, then skyrocketed by 233.49% to $697000.0 in 2022, then crashed by 158.97% to -$411000.0 in 2023, then crashed by 891.24% to -$4.1 million in 2024.
  • Its last three reported values are -$4.1 million in Q2 2024, -$411000.0 for Q1 2023, and $697000.0 during Q3 2022.